Home > Novo Nordisk Pharma, Inc. (NNPI) Products > All Products
Novo Nordisk Pharma, Inc.
(NNPI) Products
Novo Nordisk has multiple products on the market for the treatment of Diabetes, Obesity, Growth Hormone Disorders, Hemophilia and Rare Bleeding Disorders. Access information and resources on each of our products below.
Insulin Aspart Protamine and Insulin Aspart Injectable Suspension Mix 70/30
This is a premixed insulin analog indicated to improve glycemic control in patients with diabetes mellitus. Insulin Aspart Protamine and Insulin Aspart Injectable Suspension Mix 70/30 is an Unbranded Biologic of Novolog® Mix 70/30, a Novo Nordisk Inc. product.
Insulin Aspart
This is a rapid acting human insulin analog indicated to improve glycemic control in adults and children with diabetes mellitus. Insulin Aspart is an Unbranded Biologic of Novolog®, a Novo Nordisk Inc. product.
Insulin Degludec
This is a long-acting human insulin analog indicated to improve glycemic control in patients 1 year of age and older with diabetes mellitus. Insulin Degludec is an Unbranded Biologic of Tresiba®, a Novo Nordisk Inc. product.
Find NNI Product
Information
Access prescribing information, safety data sheets, and storage and stability information for all Novo Nordisk products available in the U.S.
Additional Information
Speak to a live medical representative.
If you are a healthcare provider from the United States, click below to request information directly from the Novo Nordisk Medical Information department. If you are a patient, please visit https://www.novonordisk-us.com/contact-us.html or call 1-800-727-6500
Search the Medical Information Database
The Scientific Exchange is a resource for U.S. Healthcare Professionals to learn more about disease states investigated by Novo Nordisk and our related products.
Scientific Exchange is a trademark of Novo Nordisk Health Care AG.
Novo Nordisk is a registered trademark of Novo Nordisk A/S.
Non-US Health Care Professionals, please go to www.novonordiskpro.com.
